News

Massive breakthrough: Gene-edited immune cells halt growth of stage IV gastrointestinal cancers in trial patients
The findings, published in The Lancet Oncology, hint at a new frontier in the fight against some of the deadliest forms of ...
Q&A: Two decades of research lead to treatment for rare, painful skin condition
Patients with severe dystrophic epidermolysis bullosa, or EB, have skin so fragile, the slightest touch can lead to ...